The antibody-based neutralization of FGF23 in 5/6 nephrectomized rats, a well-established experimental CKD model, increases 1,25(OH)2D3 and reduces the sHPT, but also increases serum phosphate, and thereby aortic calcification. The gene discussed is FGF23; the disease is chronic kidney disease.